Skip to main content

MoneyWorks4Me

Lupin informs about board meeting

26 Apr 2018 Evaluate

Lupin has informed that Board Meeting will be held on 15.05.2018 to consider and take on record the audited standalone and consolidated financial results for the year ended March 31, 2018 and recommend dividend, if any.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1305.00
Cipla 1350.00
Lupin 1959.05
Zydus Lifesciences 1167.00
View more..